Loading...

US Food and Drug Administration Pooled Analysis to Assess the Impact of Bone-Only Metastatic Breast Cancer on Clinical Trial Outcomes and Radiographic Assessments

PURPOSE: The outcome and proportion of patients with bone-only (BO) metastatic breast cancer (MBC) has not been well described. We sought to describe the differential outcomes of patients with BO MBC in clinical trials and explore whether there was a discrepancy in radiographic reads between investi...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Clin Oncol
Main Authors: Wedam, Suparna B., Beaver, Julia A., Amiri-Kordestani, Laleh, Bloomquist, Erik, Tang, Shenghui, Goldberg, Kirsten B., Sridhara, Rajeshwari, Ibrahim, Amna, Kim, Geoffrey, Kluetz, Paul, McKee, Amy, Pazdur, Richard
Format: Artigo
Sprog:Inglês
Udgivet: American Society of Clinical Oncology 2018
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5908220/
https://ncbi.nlm.nih.gov/pubmed/29522361
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2017.74.6917
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!